134 related articles for article (PubMed ID: 7577210)
1. Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee.
Moon TD; Brawer MK; Wilt TJ
J Natl Cancer Inst Monogr; 1995; (19):69-71. PubMed ID: 7577210
[No Abstract] [Full Text] [Related]
2. Early intervention or expectant management for prostate cancer. The Prostate Cancer Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer.
Wilt TJ; Brawer MK
Semin Urol; 1995 May; 13(2):130-6. PubMed ID: 7638470
[No Abstract] [Full Text] [Related]
3. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Intervention Versus Observation Trial: economic analysis in study design and conditions of uncertainty.
Schwartz JS
J Natl Cancer Inst Monogr; 1995; (19):73-5. PubMed ID: 7577211
[TBL] [Abstract][Full Text] [Related]
5. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
Wilt TJ; Brawer MK
J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
[TBL] [Abstract][Full Text] [Related]
6. The Prostate Cancer Intervention Versus Observation Trial (PIVOT).
Wilt TJ; Brawer MK
Oncology (Williston Park); 1997 Aug; 11(8):1133-9; discussion 1139-40, 1143. PubMed ID: 9268976
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
8. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Mayer FJ; Crawford ED
Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
[TBL] [Abstract][Full Text] [Related]
9. Ascertaining cause of death among men in the prostate cancer intervention versus observation trial.
Barry MJ; Andriole GL; Culkin DJ; Fox SH; Jones KM; Carlyle MH; Wilt TJ
Clin Trials; 2013; 10(6):907-14. PubMed ID: 23988464
[TBL] [Abstract][Full Text] [Related]
10. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of prostate cancer by radiotherapy].
Akino H; Ohyama N; Mori H; Kanamaru H; Okada K; Yoshida M; Ishii Y; Arai Y
Hinyokika Kiyo; 1997 Jun; 43(6):461-4. PubMed ID: 9250500
[TBL] [Abstract][Full Text] [Related]
12. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study.
Iversen P; Madsen PO; Corle DK
Scand J Urol Nephrol Suppl; 1995; 172():65-72. PubMed ID: 8578259
[TBL] [Abstract][Full Text] [Related]
14. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
Kirby R
Nat Clin Pract Urol; 2005 Jun; 2(6):298-303. PubMed ID: 16474812
[TBL] [Abstract][Full Text] [Related]
15. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
16. [Cancer of the prostate: what treatment for what stage?].
Vanden Bossche M
Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894
[TBL] [Abstract][Full Text] [Related]
17. Early outcomes of active surveillance for localized prostate cancer.
Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of urological malignancy: the prostate.
Doherty AP; Christmas TJ
Br J Hosp Med; 1996 Feb 7-20; 55(3):104-6, 123-4. PubMed ID: 8907872
[TBL] [Abstract][Full Text] [Related]
19. Management of stage T1b (A2) and stage T1c adenocarcinoma of the prostate.
Konety BR; Bahnson RR
Semin Urol Oncol; 1996 Aug; 14(3):183-94. PubMed ID: 8865482
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer.
Wirth MP; Weissbach L; Marx FJ; Heckl W; Jellinghaus W; Riedmiller H; Noack B; Hinke A; Froehner M
Eur Urol; 2004 Mar; 45(3):267-70; discussion 270. PubMed ID: 15036669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
